Script

NEW ALZHEIMER’S DRUG
David Winter, MD, Internal Medicine, Baylor Scott & White Health

{**ON CAM**}
TWO NEW DRUGS PROVEN TO SLOW THE PROGRESSION OF ALZHEIMER’S DISEASE … RECENTLY CLEARED REGULATORY HURDLES AND MAY SOON BECOME AVAILABLE TO PATIENTS.

{**TAKE VO**}
THAT’S AFTER ANOTHER ALZHEIMER’S MEDICATION STIRRED UP HEADLINES AND CONTROVERSY LAST YEAR AFTER IT’S EFFECTIVENESS WAS CALLED INTO QUESTION.
INTERNAL MEDICINE PHYSICIAN DAVID WINTER SAYS THESE NEWLYAPPROVED DRUGS ARE GOOD NEWS FOR THE SIX AND A HALF MILLION AMERICANS LIVING WITH ALZHEIMER’S DISEASE. HE SAYS THEY ARE SIMILAR TREATMENTS … AND BOTH ARE EXPECTED TO BE AVAILABLE BY THE END OF THE YEAR.

{**TAKE SOT**}
David Winter, MD
Internal Medicine, Baylor Scott & White Health
TRT: 20
Both these are fairly similar drugs; they can slow the progression of Alzheimer's. They don’t reverse it; they don’t make you better but keep you from getting worse.
A couple things about these – first, they’re given by IV. So, they put a needle in your arm and drip it in for an hour or so. You have to meet certain criteria to qualify for this, and they’re very expensive.

{**ON CAM**}
MEDICARE IS EXPECTED TO PAY FOR THE TREATMENT … BUT DOCTOR WINTERS SAYS SO FAR, IT SEEMS PATIENTS WILL NEED TO CONTRIBUTE AS WELL.